New Assay Sheds Light on New Strategies for Arthritis Drug - 360Dx

New Assay Sheds Light on New Strategies for Arthritis Drug  360Dx

The "drug-tolerant assay" found that only very early TNF levels offered treatment response clues in RA patients treated with the TNF inhibitor adalimumab.